Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Sachdev Amit
Relationship:  
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   71,325    

Indirect Shares

   7,447      
Direct Value   $26,276,609    

Indirect Value

   $3,536,953      
Total Shares   78,772      
Total Value   $29,813,561      


Vertex Pharmaceuticals Inc $26,276,609 Celladon Corp $0 Vertex Pharmaceuticals Inc $26,276,609 Celladon Corp $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Vertex Pharmaceuticals Inc VRTX EVP Chief Patient & Ex... 2024-05-15 55,325 2024-05-15 7,447    Premium*  
            Celladon Corp CLDN 2022-03-11 16,000 2020-03-12 0    Premium*  
* Premium Members only  

Records found :    193         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 7 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2014-11-28 4 AS $120.00 $1,440,000 D/D (12,000) 78,671 0 -
VRTX Vertex Pharmaceuticals In... EVP Chief Patient & Ext Af Off   •       –      –    2024-02-16 4 D $424.01 $1,483,187 D/D (3,498) 70,866 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2015-01-09 4 AS $125.00 $1,500,000 D/D (12,000) 78,671 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2017-07-19 4 OE $77.31 $1,546,200 D/D 20,000 119,335 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2015-03-18 4 AS $130.00 $1,560,000 D/D (12,000) 89,984 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2017-06-01 4 OE $51.75 $1,578,375 D/D 30,500 129,835 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2021-02-17 4 D $211.75 $1,612,053 D/D (7,613) 55,929 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2015-03-20 4 AS $135.08 $1,620,960 D/D (12,000) 89,984 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2012-05-07 4 OE $29.25 $1,645,313 D/D 56,250 89,858 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2022-02-24 4 D $227.86 $1,678,872 D/D (7,368) 48,210 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-05-05 4 OE $131.89 $1,761,523 D/D 13,356 48,459 0 -
VRTX Vertex Pharmaceuticals In... EVP Chief Patient & Ext Af Off   •       –      –    2024-02-20 4 AS $420.79 $1,790,041 D/D (4,254) 63,989 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2021-02-18 4 AS $210.00 $1,962,366 D/D (9,264) 46,665 0 %
VRTX Vertex Pharmaceuticals In... SVP, Global Gov. Strategy   •       –      –    2013-07-19 4 AS $88.00 $1,973,250 D/D (22,250) 28,987 0 -
VRTX Vertex Pharmaceuticals In... SVP, Global Gov. Strategy   •       –      –    2013-07-05 4 OE $32.16 $2,041,329 D/D 61,907 90,894 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2012-09-13 4 AS $55.86 $2,150,304 D/D (38,281) 21,108 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2018-07-13 4 AS $180.00 $2,165,580 D/D (12,031) 46,662 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2018-01-22 4 AS $160.00 $2,200,000 D/D (13,750) 39,163 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2019-02-04 4 AS $186.52 $2,377,296 D/D (12,722) 38,037 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2018-03-09 4 AS $175.00 $2,406,250 D/D (13,750) 46,662 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2018-01-29 4 AS $170.00 $2,564,450 D/D (15,085) 39,163 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2018-01-19 4 OE $77.31 $2,589,732 D/D 32,422 71,585 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2018-02-12 4 AS $149.22 $2,684,411 D/D (17,796) 46,662 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-02-10 4 D $240.95 $2,943,204 D/D (12,215) 59,268 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-05-11 4 AS $276.25 $3,014,014 D/D (10,665) 35,103 0 %
  193  Records found
  1   2   3   4   5   6   7  8      
  Page 7 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us